Literature DB >> 21437015

Probiotics in the management of ulcerative colitis.

Richard N Fedorak1.   

Abstract

Entities:  

Year:  2010        PMID： 21437015      PMCID： PMC3033537     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis.

Authors:  Rodrigo Bibiloni; Richard N Fedorak; Gerald W Tannock; Karen L Madsen; Paolo Gionchetti; Massimo Campieri; Claudio De Simone; R Balfour Sartor
Journal:  Am J Gastroenterol       Date:  2005-07       Impact factor: 10.864

Review 2.  Understanding why probiotic therapies can be effective in treating IBD.

Authors:  Richard N Fedorak
Journal:  J Clin Gastroenterol       Date:  2008-09       Impact factor: 3.062

3.  Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

Authors:  B J Rembacken; A M Snelling; P M Hawkey; D M Chalmers; A T Axon
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

4.  Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN).

Authors:  Harald Matthes; Thomas Krummenerl; Manfred Giensch; Corinna Wolff; Jürgen Schulze
Journal:  BMC Complement Altern Med       Date:  2010-04-15       Impact factor: 3.659

5.  The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis.

Authors:  Ajit Sood; Vandana Midha; Govind K Makharia; Vineet Ahuja; Dinesh Singal; Pooja Goswami; Rakesh K Tandon
Journal:  Clin Gastroenterol Hepatol       Date:  2009-07-22       Impact factor: 11.382
  5 in total
  10 in total

Review 1.  Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV.

Authors:  Ava Behrouzi; Hoora Mazaheri; Sarvenaz Falsafi; Zahra Hoseini Tavassol; Arfa Moshiri; Seyed Davar Siadat
Journal:  J Diabetes Metab Disord       Date:  2020-05-01

Review 2.  Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.

Authors:  Josef R Bober; Chase L Beisel; Nikhil U Nair
Journal:  Annu Rev Biomed Eng       Date:  2018-03-12       Impact factor: 9.590

3.  The Gut-Brain Axis: Literature Overview and Psychiatric Applications.

Authors:  Janine Faraj; Varun Takanti; Hamid R Tavakoli
Journal:  Fed Pract       Date:  2021-08

Review 4.  Food & mood: a review of supplementary prebiotic and probiotic interventions in the treatment of anxiety and depression in adults.

Authors:  Sanjay Noonan; Meena Zaveri; Elaine Macaninch; Kathy Martyn
Journal:  BMJ Nutr Prev Health       Date:  2020-07-06

5.  Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice.

Authors:  María-José Fábrega; Alba Rodríguez-Nogales; José Garrido-Mesa; Francesca Algieri; Josefa Badía; Rosa Giménez; Julio Gálvez; Laura Baldomà
Journal:  Front Microbiol       Date:  2017-07-11       Impact factor: 5.640

Review 6.  Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering.

Authors:  Jayshree Mishra; Madyson Stubbs; Longxiang Kuang; Nitza Vara; Priyam Kumar; Narendra Kumar
Journal:  Mediators Inflamm       Date:  2022-01-17       Impact factor: 4.711

Review 7.  Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.

Authors:  Patricia Teixeira Santana; Siane Lopes Bittencourt Rosas; Beatriz Elias Ribeiro; Ygor Marinho; Heitor S P de Souza
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

8.  Oral Feeding of Probiotic Bifidobacterium infantis: Colonic Morphological Changes in Rat Model of TNBS-Induced Colitis.

Authors:  Najma H Javed; Musaad B Alsahly; Jagdish Khubchandani
Journal:  Scientifica (Cairo)       Date:  2016-04-03

Review 9.  Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis.

Authors:  Dali Sun; Weiming Li; Shumin Li; Yunyun Cen; Qingwen Xu; Yijun Li; Yanbo Sun; Yuxing Qi; Yueying Lin; Ting Yang; Pengyuan Xu; Qiping Lu
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

10.  Anti-inflammatory Bifidobacterium strains prevent dextran sodium sulfate induced colitis and associated gut microbial dysbiosis in mice.

Authors:  Shashank Singh; Ruchika Bhatia; Pragyanshu Khare; Shikha Sharma; Sivasubramanian Rajarammohan; Mahendra Bishnoi; Sanjay Kumar Bhadada; Shyam Sunder Sharma; Jaspreet Kaur; Kanthi Kiran Kondepudi
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.